Altered trafficking of mutated growth factor receptors and their associated molecules: implication for human cancers

Shunsuke Kon1, Nobuhide Kobayashi1, Masanobu Satake1

  • 1Institute of Development, Aging and Cancer, Tohoku University; Sendai, Japan.

Cellular Logistics
|September 12, 2014
PubMed

Insights

Dysregulation of receptor tyrosine kinases (RTKs) signaling, due to impaired endocytosis or lysosomal trafficking, can lead to persistent signaling and cellular transformation. This review highlights examples of perturbed RTK downregulation mechanisms contributing to disease.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Oncology

Background:

  • Ligand-stimulated receptor tyrosine kinases (RTKs) are crucial signaling molecules involved in cellular communication.
  • Proper downregulation of RTK signaling, through endocytosis and lysosomal degradation, is essential for preventing aberrant cell growth.
  • Perturbations in RTK trafficking pathways can disrupt signal attenuation, leading to sustained signaling.

Purpose of the Study:

  • To review and present examples of perturbed RTK signal downregulation mechanisms.
  • To illustrate how defects in endocytosis and lysosomal transport of RTKs contribute to cellular transformation.
  • To explore the consequences of RTK signaling initiated at the endoplasmic reticulum/Golgi.

Main Methods:

  • Literature survey and review of existing studies on RTK signaling and trafficking.
  • Analysis of genetic alterations in RTKs, CBL, Arf GAPs, and other trafficking components.
  • Examination of RTK signaling initiated at intracellular compartments like the endoplasmic reticulum/Golgi.

Main Results:

  • Impaired endocytosis can lead to activated RTKs persisting on the plasma membrane, prolonging signaling.
  • Defective lysosomal sorting of endocytosed RTKs allows for continued signal transmission from endosomes/multivesicular bodies.
  • RTKs can initiate signaling at the endoplasmic reticulum/Golgi before reaching the plasma membrane, with potentially different downstream targets.

Conclusions:

  • Perturbations in the physiological downregulation of RTK signaling are implicated in cellular transformation and disease.
  • Both impaired internalization and defective intracellular trafficking of RTKs can lead to persistent oncogenic signaling.
  • The cellular localization of RTK signaling (cell surface vs. intracellular compartments) influences the spectrum of targeted molecules.

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.3K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.6K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

1.5K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.6K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

3.8K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.0K